Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE

Bayer : Brazil agency says Bayer-Monsanto tie-up can hurt competition, urges conditions

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/04/2017 | 08:41pm CEST
FILE PHOTO: Monsanto logo is displayed on a screen where the stock is traded on the floor of the NYSE

SAO PAULO (Reuters) - A unit of Brazil's competition regulator Cade has said Bayer AG's (>> Bayer) proposed takeover of Monsanto Co. (>> Monsanto) could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows.

SAO PAULO (Reuters) - A unit of Brazil's competition regulator Cade has said Bayer AG's (>> Bayer) proposed takeover of Monsanto Co. (>> Monsanto) could be detrimental to competition and urged conditions for Brazilian approval of the corporate tie-up, a document released on the agency's website shows.

The Bayer-Monsanto transaction, announced in September 2016, would create the world's largest integrated pesticides and seeds company.

The Cade unit said that anticipated merger-related efficiencies were insufficient to mitigate its competition concerns, according to the document dated Oct. 3.

It recommended what it termed as "structural solutions" as a condition for final approval the deal, which will be in the hands of Cade's seven-member tribunal.

Cade has 330 days to make a final decision since it began its review of the deal on April 24, a spokesman for the agency said. However, he added it may announce a ruling as early as Dec. 20.

The Cade unit said solutions included creating or strengthening another player to compete in the markets for soy and cotton seeds and in the sphere of biotech development.

But the unit has not engaged in an in-depth discussion with Bayer and Monsanto related to its suggested "remedies," the document said.

In an emailed statement to Reuters, Bayer said the unit's opinion is non-binding and does not mean the transaction will be blocked.

Hugh Grant, Monsanto's chief executive officer, said concerns expressed by Brazil's regulator are a normal step in the review process.

Brazil is Monsanto's biggest market outside of the United States.

In its second-quarter results, Bayer said sales of its crop science division tumbled more than 15 percent primarily because of its business in Brazil, an indication of the country's weight as a market for seed technology, insecticides and herbicides.

Deal opponents have asked Cade to block it or force divestments including Monsanto's Intacta RR2 IPRO soy seed technology and Bayer's glufosinate ammonium herbicides.

Last week, Monsanto's chief executive officer for South America, Rodrigo Santos, told Reuters the company was set on keeping rights to Intacta.

Cotton farmers against the transaction assert the merged company would control 14 out of 15 genetically modified cotton seed technologies available in Brazil.

If Cade orders asset disposals from the companies, authorities must see to it that the buyer is a relevant player in the biotech, seed production and crop defence segments, said attorney Rachel Mendonça, a partner at Mendonça e Nogueira Advogados.

Her law firm is representing three industry groups opposing the deal.

(Reporting by Ana Mano; editing by Alexander Smith and W Simon)

By Ana Mano

Stocks treated in this article : Monsanto, Bayer
Stocks mentioned in the article
ChangeLast1st jan.
BAYER 0.55% 73.3 Delayed Quote.-28.38%
MONSANTO 0.00%-End-of-day quote.9.57%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BAYER
07:02aBAYER : Monsanto asks U.S. court to toss $289 mln glyphosate verdict
RE
04:10aBAYER : Steps Up Legal Fight Over Weed Killer Blamed for Cancer
DJ
09/18CAN'T INTRODUCE BT COTTON TECH IN IN : Bayer AG
AQ
09/18Bayer says agriculture trade flows may change amid tariffs dispute
RE
09/18BAYER : Next Generation of Agricultural Talent Invited to 'Plant Their Path' at ..
AQ
09/18BAYER : supports rebuild after severe floods
PU
09/18BAYER : outlines its vision for the future of agriculture
PU
09/17BAYER : Puts Controlling Stake in Currenta for Sale -Reuters
DJ
09/17Bayer puts stake in chemical park operator up for sale - sources
RE
09/14BAYER AKTIENGESELLSCHAFT : Notification and public disclosure of transactions by..
EQ
More news
News from SeekingAlpha
09/18AbbVie used kickbacks to boost Humira sales - CA insurance commissioner 
09/17BASF : Too Cheap To Ignore 
09/17REUTERS : Bayer puts stake in chemical park operator up for sale 
09/14BAYER : Buy When Blood Is On The Street 
09/13YOUR CANCER HIGHLIGHT : A Pfizer-Merck KGaA Collab Bears Fruit In The Competitiv.. 
Financials (€)
Sales 2018 39 083 M
EBIT 2018 7 273 M
Net income 2018 4 895 M
Debt 2018 39 957 M
Yield 2018 3,86%
P/E ratio 2018 14,67
P/E ratio 2019 13,35
EV / Sales 2018 2,77x
EV / Sales 2019 2,22x
Capitalization 68 356 M
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 102 €
Spread / Average Target 39%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-28.38%79 493
JOHNSON & JOHNSON0.59%375 479
PFIZER18.75%252 129
NOVARTIS-1.14%215 800
ROCHE HOLDING LTD.-4.00%212 015
MERCK AND COMPANY25.15%187 284